Vilasi Annalisa, Cutillas Pedro R, Maher Anthony D, Zirah Severine F M, Capasso Giovambattista, Norden Anthony W G, Holmes Elaine, Nicholson Jeremy K, Unwin Robert J
Second University of Naples, Italy.
Am J Physiol Renal Physiol. 2007 Aug;293(2):F456-67. doi: 10.1152/ajprenal.00095.2007. Epub 2007 May 9.
The renal Fanconi syndrome is a defect of proximal tubular function causing aminoaciduria and low-molecular-weight proteinuria. Dent's disease and Lowe syndrome are defined X-linked forms of Fanconi syndrome; there is also an autosomal dominant idiopathic form (ADIF), phenotypically similar to Dent's disease though its gene defect is still unknown. To assess whether their respective gene products are ultimately involved in a common reabsorptive pathway for proteins and low-molecular-mass endogenous metabolites, we compared renal Fanconi urinary proteomes and metabonomes with normal (control) urine using mass spectrometry and (1)H-NMR spectroscopy, respectively. Urine from patients with low-molecular-weight proteinuria secondary to ifosfamide treatment (tubular proteinuria; TP) was also analyzed for comparison. All four of the disorders studied had characteristic proteomic and metabonomic profiles. Uromodulin was the most abundant protein in normal urine, whereas Fanconi urine was dominated by albumin. (1)H-NMR spectroscopic data showed differences in the metabolic profiles of Fanconi urine vs. normal urine, due mainly to aminoaciduria. There were differences in the urinary metabolite and protein compositions between the three genetic forms of Fanconi syndrome: cluster analysis grouped the Lowe and Dent's urinary proteomes and metabonomes together, whereas ADIF and TP clustered together separately. Our findings demonstrate a distinctive "polypeptide and metabolite fingerprint" that can characterize the renal Fanconi syndrome; they also suggest that more subtle and cause-specific differences may exist between the different forms of Fanconi syndrome that might provide novel insights into the underlying mechanisms and cellular pathways affected.
肾性范科尼综合征是近端肾小管功能缺陷,可导致氨基酸尿和低分子量蛋白尿。丹特病和洛氏综合征是已明确的X连锁型范科尼综合征;还有一种常染色体显性特发性形式(ADIF),其表型与丹特病相似,但其基因缺陷仍不清楚。为了评估它们各自的基因产物是否最终参与蛋白质和低分子量内源性代谢物的共同重吸收途径,我们分别使用质谱和氢核磁共振波谱,将肾性范科尼综合征患者的尿液蛋白质组和代谢组与正常(对照)尿液进行了比较。还分析了异环磷酰胺治疗继发的低分子量蛋白尿患者(肾小管蛋白尿;TP)的尿液以作比较。所研究的所有四种疾病都有特征性的蛋白质组学和代谢组学特征。尿调节蛋白是正常尿液中最丰富的蛋白质,而范科尼综合征患者的尿液中以白蛋白为主。氢核磁共振波谱数据显示范科尼综合征患者尿液与正常尿液的代谢谱存在差异,主要是由于氨基酸尿。范科尼综合征的三种遗传形式之间的尿液代谢物和蛋白质组成存在差异:聚类分析将洛氏综合征和丹特病的尿液蛋白质组和代谢组归为一组,而ADIF和TP则分别单独聚类。我们的研究结果表明有一种独特的“多肽和代谢物指纹”可用于表征肾性范科尼综合征;它们还表明,不同形式的范科尼综合征之间可能存在更细微的、病因特异性的差异,这可能为受影响的潜在机制和细胞途径提供新的见解。